Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations-Reference-Cited by-同舟云学术

Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations

Published:2011-10 Issue:10 Volume:22 Page:2179-2190
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Luckett T.,King M.T.,Butow P.N.,Oguchi M.,Rankin N.,Price M.A.,Hackl N.A.,Heading G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/10/2179/647858/mdq721.pdf

Reference49 articles.

1. A practical guide for selecting quality of life measures in clinical trials and practice;Osoba,1991

2. Measuring Disease. A Review of Disease Specific Quality of Life Measurement Scales;Bowling,2001

3. How to choose a quality of life measure;Robinson,2003

4. Assessing cancer-related quality of life across a spectrum of applications;Gotay;J Natl Cancer Inst Monogr,2004

5. The EORTC QLQ-C30 Manuals, Reference Values and Bibliography [CD Rom];EORTC Quality of Life Group,2002

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The EORTC QLQ breast modules and the FACT-B for assessing quality of life in breast cancer patients – an updated literature review;Current Opinion in Supportive & Palliative Care;2024-09-12

2. Development of a Simple Patient-reported Outcome Measurement for Terminally Ill Cancer Patients Receiving Home-based Palliative Care;Indian Journal of Palliative Care;2024-08-14

3. SOHO State of the Art Updates and Next Questions | Measuring Patient-Reported Outcomes (PROs) and Treatment Tolerability in Patients With Hematologic Malignancies;Clinical Lymphoma Myeloma and Leukemia;2024-08

4. Early palliative care and overall survival in patients with metastatic upper gastrointestinal cancers (EPIC): a multicentre, open-label, randomised controlled phase 3 trial;eClinicalMedicine;2024-08

5. Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in-Human Phase I/II Study;Pharmaceutics;2024-06-16